Praktické lékárenství – 1/2020

www.praktickelekarenstvi.cz e12 AKTUÁLNÍ FARMAKOTERAPIE DUŠEVNÍ ONEMOCNĚNÍ V POPORODNÍM OBDOBÍ: SPECIFIKA A FARMAKOTERAPIE ČÁST I: DEPRESE, ÚZKOSTNÉ PORUCHY, PORUCHY SPÁNKU A ADHD PRAKTICKÉ LÉKÁRENSTVÍ doi:10.1017/S0033291713001530 9. Mezzacappa, ES, Katlin ES. Breast-feeding is associatedwith reduced perceived stress and ne- gativemood inmothers. Health Psychology. 2002; 21(2), 187-193. doi:10.1037/0278- 6133. 21. 2.187 10. Holman DJ, Grimes MA. Patterns for the initiation of breastfeeding in humans. Am J Hum Biol. 2003; 15: 765–780. 11. Anderson PO. Drugs in lactation. Pharm Res. 2018; 35: 45. https://doi.org/10.1007/s11095- 017-2287-z 12. Anderson GD. Using pharmacokinetics to predict the effects of pregnancy and maternal- -infant transfer of drugs during lactation. Expert Opin Drug Metab Toxicol. 2006; 2: 947–960. 13. Kent JC, Mitoulas LR, Cregan MD, Ramsay DT, Doherty DA, Hartmann PE. Volume and frequency of breastfeedings and fat content of breast milk throughout the day. Pediatrics. 2006; 117: e387–95. 14. Alcorn J, McNamara PJ. Pharmacokinetics in the newborn. Adv Drug Deliv Rev. 2003; 55: 667–686. 15. Matalova P, Urbanek K, Anzenbacher P. Specific features of pharmacokinetics in children. Drug Metab Rev. 2016; 48: 70–79. 16. Howard LM, Molyneaux E, Dennis C-L, Rochat T, Stein A, Milgrom J. Non-psychotic men- tal disorders in the perinatal period. Lancet 2014;384(9956): 1775–1788. 17. Guintivano J, Sullivan PF, Stuebe AM, et al. Adverse life events, psychiatric history, and biological predictors of postpartum depression in an ethnically diverse sample of post- partum women. Psychol Med. 2018; 48(7): 1190–1200. 18. Turkcapar AF, Kadioglu N, Aslan E, et al. Sociodemographic and clinical features of po- stpartum depression among Turkish women: a prospective study. BMC Pregnancy Child- birth. 2015; 15: 108–115. 19. Paulson JF, Bazemore SD. (2010). Prenatal and postpartum depression in fathers and its association with maternal depression. JAMA. 2010; 303(19): 1961–1969. 20. Mezinárodní statistická klasifikace nemocí a přidružených zdravotních problémů: MKN- 10: Mezinárodní klasifikace nemocí a přidružených zdravotních problémů: desátá revize. Aktualizované vydání k 1. 1. 2018, Praha: Bomton Agency, 2017. 21. Šebela A, Hanka J, Mohr P. Diagnostika a moderní trendy v terapii poporodní deprese. Čes. Gynek., 2018; 83(6): 474–478. 22. Šebela A, Hanka J, Goetz M, Mohr P. Psychofarmaka během těhotenství – mírní, nebo zvyšují riziko pro plod? Část první: antidepresiva, antipsychotika. Psychiatr. praxi 2018; 19(1e): e12-e20. 23. Hart SL, Jackson SC, Boylan LM. Compromised weight gain, milk intake, and feeding behavior in breastfed newborns of depressive mothers. Journal of pediatric psychology. 2011; 36(8): 942–950. 24. Stuebe AM, Grewen K, Meltzer-Brody S. Association between maternal mood and oxy- tocin response to breastfeeding. Journal of Women’s Health. 2013; 22(4): 352–361. 25. Dias CC, Figueiredo B. Breastfeeding and depression: A systematic review of the litera- ture. Journal of Affective Disorders. 2015; 171: 142–154. 26. Righetti-Veltema M, Conne-Perréard E, Bousquet A, Manzano J. Postpartum depressi- on and mother-infant relationship at 3 months old. J Affect Disord, 2002, 70(3): 291–306. 27. Sanger C, Iles JE, Andrew CS, Ramchandani PG. Associations between postnatal mater- nal depression and psychological outcomes in adolescent offspring: a systematic review. Arch Womens Ment Health, 2015, 18(2): 147–162. 28. Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet, 2014, 384(9956): 1800–1819. 29. Austin MP, et al. Clinical practice guidelines for depression and related disorders – an- xiety, bipolar disorder and puerperal psychosis – in the perinatal period. A guideline for primary care health professionals. Committee at GEA: Melbourne, Australia, 2011. 30. Berle JO, Spigset O. Antidepressant Use During Breastfeeding. Curr Womens Health Rev. 2011; 7(1): 28–34. 31. Mohr P a kol. Klinická psychofarmakologie. Praha: Maxdorf, s. r. o. 2017. ISBN 978-80-7345-546-0 32. Larsen ER, Damkier P, Pedersen LH, et al. Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatr Scand Suppl. 2015; (445):1-28. 33. Lanza di Scalea T, Wisner KL. Antidepressant medication use during breastfeeding. ClinOb- stet Gynecol. 2009; 52(3): 483–497. 34. Figueiredo B, Conde A. Anxiety and depression in women and men from early preg- nancy to 3-months postpartum. Arch Womens Ment Health. 2011 Jun;14(3): 247–255. 35. Fairbrother N, Young A, Janssen P, Antony M, Tucker E. Depression and anxiety during the perinatal period. BMC Psychiatry. 2015; 15: 206–213. 36. Challacombe FL, Salkovskis PM, Woolgar M, Wilkinson EL, Read J, Acheson R. Parenting and mother-infant interactions in the context of maternal postpartum obsessive-compulsive disorder: Effects of obsessional symptoms and mood. Infant Behav Dev. 2016; 44: 11-20. 37. Wenzel A, Haigen E, Jackson L, Brendle J. Anxiety symptoms and disorders at eight weeks postpartum. J Anxiety Disord. 2005; 19(3): 295–311. 38. Fallon, V., Halford, J.C.G., Bennett, K.M. et al. Arch Womens Ment Health (2018) 21: 181. https://doi.org/10.1007/s00737-017-0775-0 39. Forray A, Focseneanu M, Pittman B, McDougle CJ, Epperson CN. Onset and exacer- bation of obsessive-compulsive disorder in pregnancy and the postpartum period. J Clin Psychiatry. 2010; 71(8): 1061–1068. 40. Uguz F, Akman C, Kaya N, Cilli AS. Postpartum-onset obsessive-compulsive disorder: